Global Cord Blood Corp (NYSE:CO)
| 2.42 Delayed Data As of May 27 |  +0.05 / +2.11%Today’s Change | 2.10 Today|||52-Week Range 6.31 | -42.24% Year-to-Date |
| SECTOR Health Services | INDUSTRY Medical/Nursing Services | MARKET CAP $310.0M |
Company Description
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
Contact Information
Global Cord Blood Corp. Bank of China Tower Hong Kong -- -- |
Employees
Shareholders
| Other institutional | 11.30% |
| Mutual fund holders | 1.24% |
| Individual stakeholders | -- |
Top Executives
| Ting Zheng | Chairman & Chief Executive Officer |
| Bing Chuen Chen | Chief Financial Officer & Director |
| Xin Xu | Chief Technology Officer |
| Rui Arashiyama | CEO-Guangdong & Zhejiang Divisions |
